Literature DB >> 26140086

Occult hepatitis B virus infection in Egypt.

Ashraf Elbahrawy1, Alshimaa Alaboudy1, Walid El Moghazy1, Ahmed Elwassief1, Ahmed Alashker1, Abdallah Mahmoud Abdallah1.   

Abstract

The emerging evidence of the potentially clinical importance of occult hepatitis B virus (HBV) infection (OBI) increases the interest in this topic. OBI may impact in several clinical contexts, which include the possible transmission of the infection, the contribution to liver disease progression, the development of hepatocellular carcinoma, and the risk of reactivation. There are several articles that have published on OBI in Egyptian populations. A review of MEDLINE database was undertaken for relevant articles to clarify the epidemiology of OBI in Egypt. HBV genotype D is the only detectable genotype among Egyptian OBI patients. Higher rates of OBI reported among Egyptian chronic HCV, hemodialysis, children with malignant disorders, and cryptogenic liver disease patients. There is an evidence of OBI reactivation after treatment with chemotherapy. The available data suggested that screening for OBI must be a routine practice in these groups of patients. Further studies needed for better understand of the epidemiology of OBI among Egyptian young generations after the era of hepatitis B vaccination.

Entities:  

Keywords:  Blood donors; Egypt; Hemodialysis; Hepatitis B virus; Hepatitis B virus reactivation; Hepatitis C virus; Occult hepatitis B virus infection

Year:  2015        PMID: 26140086      PMCID: PMC4483548          DOI: 10.4254/wjh.v7.i12.1671

Source DB:  PubMed          Journal:  World J Hepatol


  55 in total

Review 1.  Occult hepatitis B virus infection.

Authors:  Giovanni Raimondo; Teresa Pollicino; Irene Cacciola; Giovanni Squadrito
Journal:  J Hepatol       Date:  2006-11-07       Impact factor: 25.083

2.  Screening for hepatitis B virus infection in Egyptian blood donors negative for hepatitis B surface antigen.

Authors:  Assem M El-Sherif; Mohamed A Abou-Shady; Mohsen A Al-Hiatmy; Ashraf M Al-Bahrawy; Elham A Motawea
Journal:  Hepatol Int       Date:  2007-09-15       Impact factor: 6.047

3.  Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients.

Authors:  H E Raouf; A S Yassin; S A Megahed; M S Ashour; T M Mansour
Journal:  J Viral Hepat       Date:  2014-04-23       Impact factor: 3.728

4.  Occult hepatitis B in Egyptian thalassemic children.

Authors:  Olfat Shaker; Amal Ahmed; Inas Abdel Satar; Hamza El Ahl; Wafaa Shousha; Wahid Doss
Journal:  J Infect Dev Ctries       Date:  2012-04-13       Impact factor: 0.968

5.  Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination.

Authors:  Heba Elrashidy; Gamal El-Didamony; Ashraf Elbahrawy; Alaa Hashim; Ahmed Alashker; Mohamed Hanafy Morsy; Ahmed Elwassief; Amr Elmestikawy; Abdallah Mahmoud Abdallah; Abdel-Gawad Saeid Mohammad; Mohamed Mostafa; Nilly M George; Hafez Abdelhafeez
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.

Authors:  Fahri Yakaryilmaz; Oguz Alp Gurbuz; Sefa Guliter; Ali Mert; Yildiran Songur; Tarkan Karakan; Hatice Keles
Journal:  Ren Fail       Date:  2006       Impact factor: 2.606

7.  Occult hepatitis B virus infection among hepatitis C virus seropositive and seronegative blood donors in Alexandria, Egypt.

Authors:  Engy M El-Ghitany; Azza G Farghaly; Mona H Hashish
Journal:  J Egypt Public Health Assoc       Date:  2013-04

8.  The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

Authors:  Alessandro Zerbini; Massimo Pilli; Carolina Boni; Paola Fisicaro; Amalia Penna; Paola Di Vincenzo; Tiziana Giuberti; Alessandra Orlandini; Giuseppina Raffa; Teresa Pollicino; Giovanni Raimondo; Carlo Ferrari; Gabriele Missale
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

9.  Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.

Authors:  Tomasz I Michalak; Patricia M Mulrooney; Carla S Coffin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!

Authors:  R N Makroo; Mohit Chowdhry; Aakanksha Bhatia; Bhavna Arora; N L Rosamma
Journal:  Asian J Transfus Sci       Date:  2012-01
View more
  3 in total

1.  Polymorphisms of CYP27B1 are associated with IFN efficacy in HBeAg-positive patients.

Authors:  Yingying Wu; Yongbin Zeng; Wennan Wu; Jinpiao Lin; Qishui Ou
Journal:  J Clin Lab Anal       Date:  2018-02-18       Impact factor: 2.352

2.  Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.

Authors:  Abeer Elkady; Sayuki Iijima; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Masanori Isogawa; Yasuhito Tanaka
Journal:  World J Hepatol       Date:  2017-03-28

3.  Characterization of Antigen Escape Mutations in Chronic HBV-Infected Patients in Upper Egypt.

Authors:  Mohamed A El-Mokhtar; Helal F Hetta; Mohamed A Mekky; Doaa M Abd El-Kareem; Mohammed Ramadan; Mohammed Salah; Nahed A Mohamed; Eman A El-Masry; Sara Adel; Ibrahim M Sayed
Journal:  Infect Drug Resist       Date:  2021-06-28       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.